Study of Low Level Laser Therapy to Treat Diabetic Peripheral Neuropathy Foot Pain

Inclusion Criteria: * Existing clinical diagnosis of diabetes induced Peripheral Neuropathy documented by a suitably qualified and licensed medical professional * Significant spontaneous foot pain that occurs approximately equally (comparably) bilaterally * Significant spontaneous pain of 50 or greater on the 0-100 Visual Analog Scale (VAS) for the feet overall * Foot pain is chronic, defined as having been ongoing for at least 3 months, bilaterally * Stable anti-diabetic medication regimen for the prior 30 days or on no anti-diabetic medication regimen for the prior 30 days * Willing and able to refrain from consuming any non-study over-the-counter and/or prescription medications or therapies for the relief of pain/inflammation throughout study participation * Primary language is English. Exclusion Criteria: * No definitive clinical diagnosis of diabetes induced Peripheral Neuropathy or foot pain is undiagnosed, or diagnosed as being other than, or in addition to, diabetes induced Peripheral Neuropathy * Foot pain is unilateral or notably different between the two feet * Self-reported Degree of Pain rating on the Visual Analog Scale (VAS) pain scale is less than 50 for both feet overall * Serious organ disease or other serious primary disease merger * Diabetes ketosis, ketoacidosis or severe infection within the past 2 weeks * Current, active chronic pain disease * Cancer or treatment for cancer in the past 6 months * Use of any analgesics, or an equivalent of over-the counter or prescription NSAIDs (nonsteroidal anti-inflammatory drugs) within 7 days prior to study initiation * Use of any antidepressants within 30 days prior to study initiation * Use of any of the following prescription medications within 30 days prior to study initiation: Neurontin; Lyrica; Tramadol; Opioid medicines such as Ultram and Ultracet * Injections of local anesthetics such as lidocaine within the past 30 days * Surgical intervention to treat diabetic peripheral neuropathy foot pain, including implantation of a pain relief device * Active infection, wound or other external trauma to the treatment areas * Medical, physical, or other contraindications for, or sensitivity to, light therapy * Pregnant, breast feeding, or planning pregnancy prior to the end of study participation * Serious mental health illness such as dementia or schizophrenia; psychiatric hospitalization in past two years * Developmental disability or cognitive impairment that in the opinion of the investigator would preclude adequate comprehension of the consent form and/or ability to record study measurements * Involvement in litigation/receiving disability benefits related to the parameters of the study * Participation in other research in the past 30 days